Is Cencora Stock (COR) Halal? A Complete Analysis

The Short Answer

Cencora stock (COR) is considered halal under standard Sharia screening. Sourcing and distributing medicines is a clearly permissible activity with no haram revenue line of its own. The items to confirm are the receivables and debt ratios that come with a high-revenue, thin-margin distribution model.

Because distribution carries large receivables, confirm the receivables ratio against the board's threshold and the total-debt-to-market-cap ratio against the 33% threshold using the latest filings, and check incidental interest income against the 5% threshold and purify it.

Sharia Screening Methodology

Islamic scholars use several criteria to screen stocks:

• Business activity screen: Is the company's primary business halal?
• Debt ratio: Total debt / market cap must be under 33%
• Interest income: Interest income / total revenue must be under 5%
• Haram revenue: Revenue from haram sources must be under 5%
• Receivables ratio: Total receivables / total assets must be under 49–70% (varies by board)

Cencora's Business Activity

Cencora, Inc. (formerly AmerisourceBergen) is one of the world's largest pharmaceutical distributors. Its activity is:

• Drug distribution: Sourcing and delivering branded and generic drugs to pharmacies, hospitals, and providers
• Specialty pharmaceuticals: Distribution and services for specialty and oncology medicines
• Provider services: Logistics, technology, and support services for the healthcare supply chain

Distributing medicines is a clearly permissible activity that connects manufacturers with pharmacies and providers.

Why COR Is Halal

1. Permissible Core Business

Pharmaceutical distribution is a halal healthcare-logistics business. There is no gambling, conventional banking, or other prohibited line at the heart of the business.

2. Receivables and Debt Are the Items to Watch

Distribution is a high-revenue, thin-margin business, so the receivables ratio can be elevated. Confirm total receivables / total assets against the board's threshold (49–70%) and total debt / market cap under 33% on the latest filings before investing — these are the primary screening items.

3. Interest on Cash to Purify

Incidental interest income on cash should be confirmed against the 5% threshold and the corresponding small portion of returns purified by donating it to charity.

Current Filing-Based Quantitative Screen

Cencora's March 31, 2026 filing reports debt/assets of 15.17%, liquidity/assets of 2.67% and receivables-plus-cash/assets of 33.15%. These known asset-based ratios pass the examined limits, although the receivables ratio is close to the MSCI threshold and the filing does not provide a reproducible income numerator.

• Debt/assets: 15.17%, below the examined 33.333% limits ✅
• Receivables-plus-cash/assets: 33.15%, just below the examined MSCI 33.33% limit ⚠️
• Income numerator: Not reproducible from the filing ⚠️
• Business activity: Pharmaceutical distribution generally permissible; customer mix remains qualitative ⚠️

Methodology Interpretation

Our known asset-based calculations pass the stored FTSE Yasaar, MSCI and Malaysia ratio sets, but the market-cap denominator and income numerator are not calculated. The qualitative distribution assessment remains incomplete, so this page does not claim an unconditional universal classification.

Bottom Line

Cencora (COR) is halal for Muslim investors when the ratio screens pass. The drug-distribution business is permissible; the main caveats are confirming the receivables ratio and total debt / market cap on the latest filings, while purifying the minor portion of returns attributable to interest income on cash.

For Muslim investors seeking healthcare-distribution exposure, compare COR with peers like McKesson (MCK), Cardinal Health (CAH), and Henry Schein (HSIC).